|
WO2020016732A1
|
|
Composition comprising glycyrrhin and cosmetic and pharmaceutical uses thereof
|
|
US7321000B2
|
|
Ophthalmic composition containing N-acetyl-cysteine for the treatment of dry-eye syndrome
|
|
EP1383512A1
|
|
Use of sucralfate for the treatment of cervical erosion
|
|
AU4609900A
|
|
Ophthalmic compositions for the treatment of visual disorders characterised by areduced contrast sensitivity
|
|
AU3324100A
|
|
Use of pirenoxine for the protection of corneal tissues in photokeratectomy
|
|
AU3324000A
|
|
Use of niaouli essential oil as transdermal permeation enhancer
|
|
US6346273B1
|
|
Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles
|
|
AU3863297A
|
|
Bioadhesive complexes of polycarbophil and azole antifungal or antiprotozoal drugs
|
|
WO9728787A1
|
|
Ophthalmic solutions viscosified with tamarind seed polysaccharide
|
|
EP0459182A2
|
|
Containers for lyophilized pharmaceutical products
|
|
IT9068059D0
|
|
Anti-inflammatory preparation for ophthalmic use.
|
|
EP0361566A1
|
|
Derivatives of 7-amino 2-dialkylaminoalkyl-1H-pyrrol[3.4-c] pyridine-1.3(2H)-dione with effect against cataract
|
|
IT8568074D0
|
|
Biologically active non-informational poly:desoxy:ribonucleotide prepn
|
|
FR2488889A1
|
|
N-di:ethylamino:ethyl-phthalimide derivs. - are antiarrhythmic agents and local anaesthetics
|
|
GB2082569A
|
|
Phthalimides
|
|
DE3030695A1
|
|
N-di:ethylamino:ethyl-phthalimide derivs. - are antiarrhythmic agents and local anaesthetics
|
